SOTERA HEALTH COMPANY (SHC)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SHC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SHC | Director | 68 | ["extensive experience in the biopharmaceutical industry","expertise in global health policy and regulatory affairs","expertise in product quality and patient safety"] | ["Audit Committee","LDC Committee","LDC","NCG"] | 2026 |
Biography sourced from the proxy statement filing.
David E. Wheadon, M.D., Age 68, has served as a member of our Board since 2021. Dr. Wheadon is a member of the Audit Committee and the Nominating and Corporate Governance Committee. He received cash compensation of $85,000 and stock awards valued at $234,558 in 2025, for total compensation of $319,558.